search
Back to results

The Heart Institute of Spokane Diet Study

Primary Purpose

Myocardial Infarction

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
American Heart Association Step 2 diet
Mediterranean diet
Sponsored by
Providence Health & Services
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myocardial Infarction focused on measuring Cardiovascular disease, Nutrition, Mediterranean diet, Low fat diet, American Heart Association diet, Monounsaturated fats, Omega-3 fats, Outcomes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: First myocardial infarction Exclusion Criteria: Prior myocardial infarction Uncontrolled or secondary hypertension New York Heart Association heart failure stage III or IV Ventricular arrythmias requiring medical or defibrillatory intervention Other diseases that may make study completion difficult or unlikely

Sites / Locations

  • Providence Medical Research Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Mediterranean diet,

American Heart Association Step 2 diet

Case controlled

Arm Description

Outcomes

Primary Outcome Measures

Fatal/non-fatal myocardial infarction
The primary outcome was a composite of end points including all-cause and cardiac deaths, MI, hospital admissions for heart failure, unstable angina, or stroke.
Cardiovascular death
Non-cardiovascular death
Stroke/TIA
Admission for congestive heart failure or unstable angina

Secondary Outcome Measures

Cardiovascular revascularization
Peripheral revascularization or amputation
Doubling of serum creatinine,dialysis,or kidney transplant
New hypertension
New diabetes
Risk factors (traditional and novel)

Full Information

First Posted
December 22, 2005
Last Updated
August 23, 2010
Sponsor
Providence Health & Services
Collaborators
The Heart Institute of Spokane, Providence Medical Research Center, Washington State Attorney General's Office, Deaconess Medical Center, Spokane, Washington
search

1. Study Identification

Unique Protocol Identification Number
NCT00269425
Brief Title
The Heart Institute of Spokane Diet Study
Official Title
The Heart Institute of Spokane Diet Intervention and Evaluation Trial (THIS DIET)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2005
Overall Recruitment Status
Completed
Study Start Date
October 2000 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
January 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Providence Health & Services
Collaborators
The Heart Institute of Spokane, Providence Medical Research Center, Washington State Attorney General's Office, Deaconess Medical Center, Spokane, Washington

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether a Mediterranean style diet, enriched in monounsaturated and omega-3 fats, is superior to the American Heart Association Step 2 diet, a traditional low fat diet, for improving rates of survival and cardiovascular complications in persons who have had a first myocardial infarction (heart attack).
Detailed Description
Cardiovascular diseases (heart attack, stroke, and other vascular diseases) are major causes of mortality in developed countries. Although medicines and revascularization procedures prolong lives, rates of death and disability remain high. Lifestyle factors greatly contribute to risk. Yet, scientific data regarding the role of lifestyle change in prevention and treatment are limited. In the nutrition area, limitations include observational or uncontrolled study design, and focus on surrogate markers rather than on clinical outcomes. Excess dietary fat has long been associated with cardiovascular diseases. Increased risk is related both to types of fat and calories from fat. Saturated fat, cholesterol, and trans-fatty acids have all been associated with adverse outcomes. Because fat is calorie-laden, high fat diets are commonly associated with weight gain and obesity. Low-fat diets have traditionally been recommended to control lipids and weight. However, these diets are high in carbohydrate and may actually be associated with weight gain if calories are not limited. Such diets have also been associated with worsening of hyperinsulinemia and insulin resistance and an adverse lipid pattern (low HDL cholesterol and high triglyceride levels). In contrast, increased intake of monounsaturated and omega-3 fats is associated with favorable effects on cardiovascular risk factors and markers including: endothelial function, lipids, and levels of insulin and glucose. Results have been consistent across various groups of high-risk patients, including those with hypercholesterolemia, diabetes, and hypertension. Most importantly, a Mediterranean style diet enriched in monounsaturated and omega-3 fats reduced death and cardiovascular complications after myocardial infarction (MI) in the Lyon Heart study. The American Heart Association (AHA) Step 2 is a low-fat diet traditionally recommended for people with cardiovascular disease. The Mediterranean and AHA Step 2 diets differ primarily in the amount of monounsaturated and omega-3 fats, both of which are higher in the Mediterranean diet. Both diets are low in saturated fat (less than 7%) and cholesterol (less than 200 mg/d). Although the Lyon Heart Study compared a Mediterranean diet to a "prudent Western diet," a low fat diet similar to the AHA diet, the latter group did not achieve recommended intake levels of saturated fat or cholesterol. Furthermore, there was no longitudinal nutritional intervention in the low fat diet group. Therefore, the effect of nutritional intervention per se was not addressed. Comparison(s): In survivors of a first MI, two longitudinal nutritional interventions, a Mediterranean style diet and an AHA Step 2 diet, will be compared. Both intervention groups will be compared to an untreated control group from our clinical database.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Infarction
Keywords
Cardiovascular disease, Nutrition, Mediterranean diet, Low fat diet, American Heart Association diet, Monounsaturated fats, Omega-3 fats, Outcomes

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
202 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Mediterranean diet,
Arm Type
Experimental
Arm Title
American Heart Association Step 2 diet
Arm Type
Experimental
Arm Title
Case controlled
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
American Heart Association Step 2 diet
Other Intervention Name(s)
Low fat diet
Intervention Description
Low fat diet with patient education and diet analysis
Intervention Type
Behavioral
Intervention Name(s)
Mediterranean diet
Intervention Description
Mediterranean style diet with patient education and diet analysis
Primary Outcome Measure Information:
Title
Fatal/non-fatal myocardial infarction
Description
The primary outcome was a composite of end points including all-cause and cardiac deaths, MI, hospital admissions for heart failure, unstable angina, or stroke.
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Cardiovascular death
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Non-cardiovascular death
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Stroke/TIA
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Admission for congestive heart failure or unstable angina
Time Frame
3,6,12,18,24,36,48,60,72 months
Secondary Outcome Measure Information:
Title
Cardiovascular revascularization
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Peripheral revascularization or amputation
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Doubling of serum creatinine,dialysis,or kidney transplant
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
New hypertension
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
New diabetes
Time Frame
3,6,12,18,24,36,48,60,72 months
Title
Risk factors (traditional and novel)
Time Frame
3,6,12,18,24,36,48,60,72 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: First myocardial infarction Exclusion Criteria: Prior myocardial infarction Uncontrolled or secondary hypertension New York Heart Association heart failure stage III or IV Ventricular arrythmias requiring medical or defibrillatory intervention Other diseases that may make study completion difficult or unlikely
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katherine R. Tuttle, MD,FASN,FACP
Organizational Affiliation
Providence Medical Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Providence Medical Research Center
City
Spokane
State/Province
Washington
ZIP/Postal Code
99204
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Heart Institute of Spokane Diet Study

We'll reach out to this number within 24 hrs